Next Biomedical Co.,Ltd. (KOSDAQ:389650)

South Korea flag South Korea · Delayed Price · Currency is KRW
39,700
+700 (1.79%)
At close: May 13, 2025, 3:30 PM KST
47.04%
Market Cap 321.10B
Revenue n/a
Net Income n/a
Shares Out 8.09M
EPS n/a
PE Ratio n/a
Forward PE n/a
Dividend n/a
Ex-Dividend Date n/a
Volume 58,193
Average Volume 63,925
Open 38,800
Previous Close 39,000
Day's Range 38,800 - 40,700
52-Week Range 21,400 - 60,800
Beta n/a
RSI 44.31
Earnings Date n/a

About Next Biomedical

Next Biomedical Co.,Ltd. engages in the research and development, production, and development of therapeutics, drug delivery system and drug-medical device products in South Korea. It offers hemostatic material for endoscope; and microspheres for vascular embolization. The company was founded in 2014 and is based in Incheon, South Korea. [Read more]

Industry Electromedical and Electrotherapeutic Apparatus
Founded 2014
Country South Korea
Stock Exchange KOSDAQ
Ticker Symbol 389650
Full Company Profile

News

There is no news available yet.